跳至主要内容
临床试验/IRCT20120703010178N19
IRCT20120703010178N19招募中2 期

Evaluation of prevalence of Augmented renal clearance (ARC) and serum concentration of Meropenem with two different dosing regimens in critically ill patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • serum creatinin 0.7mg/dl and lower
  • Sequential Organ Failure Assessment (SOFA) score 4 and lower
  • Augmented renal clearance (ARC ) scoring 7 and higher
  • Augmented renal clearance in trauma intensive Care (ARCTIC) scoring 7 and higher
  • 12 hour - Clearance creatinin 130 ml/min and higher

排除标准

  • Pregnancy and Lactation
  • Age lower than 18 yr

研究者

相似试验

Augmented renal clearance (ARC) and Meropenem... | 临床试验